Cervical Cancer

According to a survey released by the National Women's Health Resource Center (NWHRC), a non-profit organization dedicated to health education, many Seattle women lack an understanding about cervical cancer and are not accessing the tools to prevent it. The survey shows that while 79 percent of Seattle women surveyed have seen or read about the human papillomavirus (HPV), only half (53 percent) believe cervical cancer can be prevented—despite the availability of HPV-based prevention tools.

According to a survey released by the National Women's Health Resource Center (NWHRC), a non-profit organization dedicated to health education, many Chicago women lack an understanding about cervical cancer and are not accessing the tools to prevent it. The survey shows that while 81 percent of Chicago women surveyed have seen or read about the human papillomavirus (HPV), less than half (48 percent) believe cervical cancer can be prevented - despite the availability of HPV-based prevention tools.

The Utah Department of Health (UDOH) is ‘going viral’ to do battle against the human papillomavirus (HPV). The UDOH Cancer Control Program (UCCP) has launched the Cervical Cancer Prevention Contest to get young men and women talking about how to prevent the disease that is most often caused by the sexually-transmitted HPV infection.

It is not consistent to stop screening women after age 50 because the risk of cervical cancer - even after several negative smear results - is similar to that at younger ages, concludes a study published on bmj.com today.

When it comes to cervical cancer, many St. Louis women are not accessing the tools available to protect themselves from this preventable disease, according to recent survey findings released by the National Women's Health Resource Center (NWHRC), a non-profit organization dedicated to providing health education to women. The survey shows that while many St. Louis women are aware of important prevention tools like the HPV vaccine, the Pap test and the HPV test, they are missing the annual physician visits where they could receive these technologies.

The Department of Health has joined forces with the Immunisation Alliance of Western Australia and a cervical cancer survivor to urge young women to take up the free cervical cancer vaccine.

Michelle Arrowsmith was just 31-years-old when she was diagnosed with cervical cancer in 2006 and underwent urgent life-saving surgery.

Jade Goody, the British reality TV star, has died of cervical cancer at age 27. It is reported that she died quietly in her sleep Sunday, March 22, 2009. She had lived the past 7 years of her life in front of the camera. She leaves behind her new husband, Jack Tweed, and her two sons, Freddie and Bobby Jack.

Jade Goody became a face for cervical cancer. Her story inspired many to have Pap smears. It is being called the “Jade Goody effect.”

A panel of experts is to carry out an evidence review to determine whether women under the age of 25 should be routinely screened for cervical cancer, Health Minister Ann Keen announced today.

Cervical screening currently starts at age 25 years in England, in line with World Health Organisation recommendations and the advice of leading experts in this country including the independent Advisory Committee on Cervical Screening (ACCS).

All girls and young women in Wales born between 1 September 1991 and 31 August 1995 will be offered the human papillomavirus (HPV) vaccine during school year 2009-10, announced Health Minister Edwina Hart.

The Welsh Assembly Government is investing about £9 million to accelerate the planned two-year catch-up campaign to ensure that an additional 40,000 girls and young women are offered protection against cervical cancer.

This follows the success of the inaugural routine programme which began last Autumn for some 20,000 girls aged 12 – 13 years old.

The U.S. Food and Drug Administration yesterday approved the first DNA test that identifies the two types of human papillomavirus (HPV) that cause the majority of cervical cancers among women in the United States.

The test, called Cervista HPV 16/18, detects the DNA sequences for HPV type 16 and HPV type 18 in cervical cells. Differentiating these HPV types gives health care professionals more information on a patient’s risk of subsequently developing cervical cancer.